Corcept Therapeutics Incorporated (Nasdaq: CORT) announced that it has sold to an investment fund managed by Pharmakon Advisors a synthetic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE